Therapeutic Asset Ratings
383 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Survaxm
Diffuse Intrinsic Pontine Glioma
Children's Oncology Group
P1
CC
(41)
Tegavivint
Melanoma
Children's Oncology Group
P1/2
CC
(41)
Tegavivint
Pancreatic Ductal Adenocarcinoma
Children's Oncology Group
P1/2
CC
(41)
FLUDEOXYGLUCOSE
Melanocytic Skin Neoplasm
Children's Oncology Group
N/A
D
(30)
FLUDEOXYGLUCOSE
Melanocytic Neoplasm
Children's Oncology Group
N/A
D
(30)
azd1390
Diffuse Intrinsic Pontine Glioma
Children's Oncology Group
P1
NR
(0)
azd1390
Diffuse Midline Glioma, H3 K27-Altered
Children's Oncology Group
P1
NR
(0)
azd1390
Pediatric High-Grade Glioma
Children's Oncology Group
P1
NR
(0)
Showing 376 to 383 of 383 assets
Previous
Page 16 of 16
Next
